Dihydrolipoamide dehydrogenase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 47: Line 47:
**[[2f5z]], [[1zy8]] – hDLD E3 + pyruvate dehydrogenase E3-binding domain<br />
**[[2f5z]], [[1zy8]] – hDLD E3 + pyruvate dehydrogenase E3-binding domain<br />
**[[1zmc]], [[1zmd]] – hDLD + NAD<br />
**[[1zmc]], [[1zmd]] – hDLD + NAD<br />
-
**[[5j5z]] – hDLD (mutant) + FAD <br />
+
**[[6i4q]] – hDLD + FAD <br />
 +
**[[5j5z]], [[6hg8]], [[6i4p]], [[6i4r]], [[6i4s]], [[6i4t]], [[6i4u]], [[6i4z]] – hDLD (mutant) + FAD <br />
**[[2ii3]], [[2ii4]], [[2ii5]] – bDLD + CoA<br />
**[[2ii3]], [[2ii4]], [[2ii5]] – bDLD + CoA<br />
**[[1v59]] – yDLD + NAD<br />
**[[1v59]] – yDLD + NAD<br />

Revision as of 08:58, 14 July 2020

FAD-containing dihydrolipoamide dehydrogenase complexed with NAD 1lvl

Drag the structure with the mouse to rotate

3D structures of dihydrolipoamide dehydrogenase

Updated on 14-July-2020

References

  1. Brautigam CA, Wynn RM, Chuang JL, Machius M, Tomchick DR, Chuang DT. Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex. Structure. 2006 Mar;14(3):611-21. Epub 2006 Jan 26. PMID:16442803 doi:10.1016/j.str.2006.01.001
  2. Voet, Donald et al. 2008. Fundamentals of Biochemistry. 3rd ed. pp.570-575
  3. Brassier A, Ottolenghi C, Boutron A, Bertrand AM, Valmary-Degano S, Cervoni JP, Chretien D, Arnoux JB, Hubert L, Rabier D, Lacaille F, de Keyzer Y, Di Martino V, de Lonlay P. Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome. Mol Genet Metab. 2013 May;109(1):28-32. doi: 10.1016/j.ymgme.2013.01.017. Epub, 2013 Feb 1. PMID:23478190 doi:http://dx.doi.org/10.1016/j.ymgme.2013.01.017
  4. Voet, Donald et al. 2008. Fundamentals of Biochemistry. 3rd ed. p.585
Personal tools